Comparison of Graft-Versus-Host Disease-Free, Relapse-Free Survival (GRFS) of Patients With Hematological Malignancy According to Donor Type: JSHCT Working Group Study
Biology of Blood and Marrow Transplantation - Netherlands
doi 10.1016/j.bbmt.2015.11.926
Full Text
Open PDFAbstract
Available in full text
Date
March 1, 2016
Authors
Publisher
Elsevier BV